• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
NYR 0.00% 2.1¢

NYRADA INC.

Healthcare

Nyrada Inc is an Australia-based drug development company. The Company focuses on... Nyrada Inc is an Australia-based drug development company. The Company focuses on development of small molecule drugs pertaining to the underlying pathological processes involved in cardiovascular, neurodegenerative and chronic inflammatory diseases. Its drug development programs include a proprotein convertase subtilisin/kexin type nine (PCSK9) inhibitor for the treatment of high blood low-density lipoprotein (LDL)-cholesterol levels in patients poorly responsive to or unable to take statin drugs. It develops a neuroprotectant drug to reduce the impact of long-term disability in patients with ischaemic stroke and traumatic brain injury. The Company also develops a drug to treat pain associated with peripheral nerve damage and autoimmune diseases such as psoriasis.More

RCE'S BREAKTHROUGH

Recce Pharmaceuticals (ASX:RCE) poised to revolutionise the treatment of deadly infections – is R327 the muti-billion dollar answer to super bugs? NEWS: Recce Pharmaceuticals speeds up R327 dose as it works to bring new anti-infective to market

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
NYR 05:07 14 8.0K
05:07 Last post  Boondog Comments Created with Sketch.  14  Views Created with Sketch.  8.0K 
NYR 20/11/23 0 192
20/11/23 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  192 
NYR 20/11/23 0 187
TRENDING NEWS

Wealth Within’s Hot Stock Tips launches in partnership with HotCopper and The Market Herald

NEWS
28 Nov 2023
20/11/23 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  187 
NYR 20/11/23 0 148
20/11/23 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  148 
NYR 01/11/23 0 330
01/11/23 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  330 
NYR 17/10/23 0 253
17/10/23 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  253 
NYR 17/10/23 0 193
17/10/23 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  193 
NYR 13/10/23 0 363
13/10/23 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  363 

See All Discussions arrow Created with Sketch.

Timeline

Nyrada Annual General Meeting Results
20 Nov 11:45
 
Nyrada AGM 2023 CEO Presentation
20 Nov 09:05
 
Nyrada AGM 2023 Chair Address
20 Nov 08:18
 
2023 AGM Chair Letter to Shareholders
01 Nov 08:18
 
2023 AGM Notice of Meeting and Proxy
17 Oct 08:43
 
2023 AGM Letter to Shareholders and Proxy
17 Oct 08:16
 
View More arrow Created with Sketch.
(20min delay)
Last
2.1¢
Change
0.000(0.00%)
Mkt cap ! $3.276M
Open High Low Value Volume
2.1¢ 2.1¢ 2.1¢ $14.48K 689.7K

Buyers (Bids)

No. Vol. Price($)
1 8501 2.1¢
 

Sellers (Offers)

Price($) Vol. No.
3.0¢ 200000 1
View Market Depth
Last trade - 14.18pm 28/11/2023 (20 minute delay) ?
NYR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.